Can the healthcare system catch up to GLP-1 drug use? Millions of patients are now taking drugs like Ozempic and Wegovy, but clinicians still struggle to predict who will benefit and how best to support lasting results.

https://www.drugdiscoverynews.com/can-the-healthcare-system-catch-up-to-glp-1-drug-use-17108?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-8sSWIm6PTx-qU70Hph8TfzWJLoIPMo7g4IBR04kxqsYNU_z8DvF2JGpg-wbvaG5gEUYFpPVN3hl-V2vVkrUEDKSUAJhw&_hsmi=412801160&utm_content=412801160&utm_source=hs_email When GLP-1 drugs first entered clinical practice nearly two decades ago, few could have predicted how quickly they would escape the confines of endocrinology and enter everyday conversation. Today, medications like Ozempic and Wegovy are discussed not just in clinics and conferences, but on social media, red carpets, and group chats — often framed as lifestyle enhancers rather than powerful, lifelong medications.